Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
02:08pm, Sunday, 19'th May 2024
Following the so-called “smart money” is often a wise strategy for retail investors. Most individual investors fail to outperform the broader market over the long-run.
Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised
11:51am, Monday, 13'th May 2024
Insulet's (PODD) first-quarter performance benefits from the continued high demand for Omnipod 5.
Insulet Corporation (PODD) Q1 2024 Earnings Call Transcript
08:34pm, Thursday, 09'th May 2024
Insulet Corporation (NASDAQ:PODD ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President and Chi
Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
06:31pm, Thursday, 09'th May 2024
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare t
Insulet misses first-quarter profit estimates as marketing costs weigh
05:51pm, Thursday, 09'th May 2024
Insulet Corp reported first-quarter profit that missed market expectations on Thursday, weighed by higher marketing expenses, sending shares of the medical device maker down 3.7% in extended trading.
Insulet's 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth
06:00am, Tuesday, 07'th May 2024
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today released i
Gear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics
10:21am, Monday, 06'th May 2024
Besides Wall Street's top -and-bottom-line estimates for Insulet (PODD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Insulet (PODD) Rises Higher Than Market: Key Facts
07:16pm, Thursday, 02'nd May 2024
In the most recent trading session, Insulet (PODD) closed at $173.42, indicating a +1.85% shift from the previous trading day.
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term
10:55am, Thursday, 02'nd May 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Insulet (PODD) Outperforms Broader Market: What You Need to Know
07:16pm, Friday, 26'th Apr 2024
Insulet (PODD) reachead $166.19 at the closing of the latest trading day, reflecting a +1.23% change compared to its last close.
Insulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
09:46am, Wednesday, 24'th Apr 2024
Strong global new customer starts fueled by the ongoing Omnipod 5 demand are expected to significantly benefit Insulet's (PODD) first-quarter performance.
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
08:50am, Friday, 19'th Apr 2024
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Wednesday, 17'th Apr 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
7 Stable Stocks for 50% Returns by Early 2025
09:45am, Monday, 15'th Apr 2024
Investors who seek 50% returns in less than 12 months generally will have many choices within stable stocks. The general maxim regarding risk and return applies here: Risky, unstable stocks tend to of
Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report?
01:16pm, Friday, 12'th Apr 2024
Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
